Bioequivalence of Two Different Sources of Eslicarbazepine Acetate
Clinical trial NCT03116321 · COMPLETED
Trial details
- NCT number
- NCT03116321
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-03
- Primary completion
- 2017-01-05
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.